RICHARD ALDRICH
CIK 1185039 · last filed 2023-03-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$120.20M
Companies
12
Total Filings
101
Lifetime Open-Market Net
$22.50M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Director | 0 | $8.37 | $0 | -$1.19M | 20 | 2023-03-06 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Director | 70,306 | $15.90 | $1.12M | $0 | 1 | 2018-12-11 |
| KALV | Director | 934,484 | $27.00 | $25.23M | $4.87M | 5 | 2018-10-05 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Director | 1,043,276 | — | — | $8.55M | 37 | 2018-10-02 |
| PTCT | Director | 1,050,104 | $75.14 | $78.90M | $11.11M | 5 | 2015-06-10 |
| VSTM | Director | 3,276,983 | $4.10 | $13.44M | $270.2K | 23 | 2013-11-12 |
| BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted | 10%+ Owner | 690,309 | — | — | $6.69M | 4 | 2008-11-14 |
| SEQUENOM INC (SQNM) Delisted | 10%+ Owner | 5,872,966 | — | — | $0 | 1 | 2008-07-14 |
| CRIS | 10%+ Owner | 6,250,564 | $0.42 | $2.63M | -$9.10M | 1 | 2008-04-17 |
| ARADIGM CORP (ARDM) Delisted | 10%+ Owner | 7,568,410 | — | — | $1.30M | 1 | 2008-01-16 |
| Sirtris Pharmaceuticals, Inc. (SIRT) Delisted | Director | 38,095 | — | — | $0 | 1 | 2007-05-31 |
| LIPID SCIENCES INC/ (LIPD) Delisted | 10%+ Owner | 3,713,962 | — | — | $1.7K | 1 | 2007-03-28 |
Recent Filings · Page 5 of 11
101 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-04-04 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +1,119 | $0 | EDGAR |
| 2016-03-25 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +59,800 | $567.2K | EDGAR |
| 2016-03-23 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +59,800 | $624.5K | EDGAR |
| 2016-03-21 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +59,700 | $493.0K | EDGAR |
| 2016-03-17 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +59,029 | $466.1K | EDGAR |
| 2016-03-15 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +162,732 | $1.24M | EDGAR |
| 2016-01-05 | Tempest Therapeutics, Inc. (OVAS) Delisted | Mixed | +1,087 | $0 | EDGAR |
| 2015-12-17 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Sell (S) | −20,000 | -$395.2K | EDGAR |
| 2015-10-02 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +1,251 | $0 | EDGAR |
| 2015-08-28 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Gift (G) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.